Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antibiotics >  β-Lactamase inhibitors >  CARUMONAM

CARUMONAM

Basic information Safety Supplier Related

CARUMONAM Basic information

Product Name:
CARUMONAM
Synonyms:
  • CARUMONAM
  • Acetic acid, [[(Z)-[2-[[(2S,3S)-2-[[(aminocarbonyl)oxy]methyl]-4-oxo-1-sulfo-3-azetidinyl]amino]-1-(2-amino-4-thiazolyl)-2-oxoethylidene]amino]oxy]-
  • Acetic acid, [[[2-[[2-[[(aminocarbonyl)oxy]methyl]-4-oxo-1-sulfo-3-azetidinyl]amino]-1-(2-amino-4-thiazolyl)-2-oxoethylidene]amino]oxy]-, [2S-[2α,3α(Z)]]-
  • AMA 1080
  • Antibiotic Ro 17-2301
  • Ro 17-2301
  • (2S)-2α-(Carbamoyloxymethyl)-3α-[[(Z)-(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-4-oxoazetidine-1-sulfonic acid
  • [[[(Z)-2-[[(2S)-2α-[[(Aminocarbonyl)oxy]methyl]-4-oxo-1-sulfoazetidin-3α-yl]amino]-1-(2-aminothiazol-4-yl)-2-oxoethylidene]amino]oxy]acetic acid
CAS:
87638-04-8
MF:
C12H14N6O10S2
MW:
466.4
Mol File:
87638-04-8.mol
More
Less

CARUMONAM Chemical Properties

alpha 
D26 -45° (c = 1 in DMSO)
Density 
2.13±0.1 g/cm3(Predicted)
pka
-0.43±0.60(Predicted)
More
Less

CARUMONAM Usage And Synthesis

Description

Canunonam is an injectable antibiotic, the second monobactam ever developed (the first being Squibb’s aztreonam). It is highly active against Gram negative bacteria, particularly pseudomom, and is reportedly effective in the treatment of pneumonia, cystitis, peritonitis and secondary infections.

Originator

Takeda (Japan)

Definition

ChEBI: An N-sulfonated monobactam antibiotic.

brand name

Amasulin

Antimicrobial activity

A synthetic monobactam with activity against common pathogenic organisms similar to that of aztreonam. It is resistant to hydrolysis by the common plasmid and chromosomal β-lactamases, but it can be hydrolyzed by ESBLs.
It is administered intravenously, achieving a concentration of c. 78 mg/L after a 20-min infusion of 1 g. The plasma halflife is 1.7 h and the plasma protein binding 18–28%. Carumonam is almost entirely eliminated in the glomerular filtrate, probenecid having no effect on excretion; 96% of labeled compound is found in the urine, with 3% in the feces. Between 68% and 91% of the dose appears in the urine within 24 h.
Side effects and clinical use are similar to those of aztreonam.

CARUMONAM Preparation Products And Raw materials

Raw materials

CARUMONAMSupplier

Chembest Research Laboratories Limited
Tel
021-20908456-
Email
sales@BioChemBest.com
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725;010-86181995
Email
waley188@sohu.com
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-58378339;025-57798810
Email
sales@sunlidabio.com;sales@sunlidabio.com
GIHI CHEMICALS CO.,LTD
Tel
0086-571-86217390
Email
Sales@gihichem.com
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Email
sales02@forever-reagent.com